Time as a Variable With Niacin Extended‐Release/Lovastatin vs. Atorvastatin and Simvastatin
Author:
Affiliation:
1. From the Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY;1 and Kos Pharmaceuticals, Miami, FL2
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.0197-3118.2005.04289.x
Reference43 articles.
1. Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])
2. Once-Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
4. Lovastatin and Extended-Release Niacin Combination Product: The First Drug Combination for the Management of Hyperlipidemia
5. Physicians' Desk Reference 2004 Thomson PDR Niaspan (niacin extended‐release tablets) product information 1797 1801
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Density and viscosity study of nicotinic acid and nicotinamide in dilute aqueous solutions at and around the temperature of the maximum density of water;The Journal of Chemical Thermodynamics;2014-09
2. “Sick Fat,” Metabolic Disease, and Atherosclerosis;The American Journal of Medicine;2009-01
3. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: A primer for clinicians;Drugs of Today;2008
4. Lowering Low-Density Lipoprotein Cholesterol Levels to Reduce Atherosclerotic Coronary Heart Disease Risk;Therapeutic Lipidology;2007
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3